(Q39862474)

English

WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation

scientific article published on 9 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

15 September 2017

1 reference

based on heuristic

inferred from title

author name string

G Weber

1

1 reference

Europe PubMed Central

15 September 2017

J Karbach

2

1 reference

Europe PubMed Central

15 September 2017

S Kuçi

3

1 reference

Europe PubMed Central

15 September 2017

H Kreyenberg

4

1 reference

Europe PubMed Central

15 September 2017

A Willasch

5

1 reference

Europe PubMed Central

15 September 2017

E Koscielniak

6

1 reference

Europe PubMed Central

15 September 2017

T Tonn

7

1 reference

Europe PubMed Central

15 September 2017

T Klingebiel

8

1 reference

Europe PubMed Central

15 September 2017

W S Wels

9

1 reference

Europe PubMed Central

15 September 2017

E Jäger

10

1 reference

Europe PubMed Central

15 September 2017

P Bader

11

1 reference

Europe PubMed Central

15 September 2017

publication date

9 April 2009

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

23

1 reference

Europe PubMed Central

15 September 2017

9

1 reference

Europe PubMed Central

15 September 2017

1634-1642

1 reference

Europe PubMed Central

15 September 2017

https://scigraph.springernature.com/pub.10.1038/leu.2009.70

0 references

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Antigen-specific cellular immunotherapy of leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

SK-NEP-1 and Rh1 are Ewing family tumor lines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

The candidate Wilms' tumour gene is involved in genitourinary development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Immunohistochemical findings in embryonal small round cell tumors with molecular diagnostic confirmation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

21 January 2018

Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical detection of WT1 protein in a variety of cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer immunotherapy targeting Wilms' tumor gene WT1 product

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA class I and II expression in rhabdomyosarcomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2009.70

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39862474&oldid=2091685887"